OakChart

Mustang Bio Inc

MBIOHealthcare·Biotechnology·USA·Nano·NASD·Nov 11 • 3:52 PM ET

0.4277-0.0229 (-5.08%)
2026-11-12 06:41 CET
Market cap
3.24 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-3.53 USD m
Free cash flow, TTM
-4.57 USD m
EPS diluted, TTM
-0.52
P/E
-
Compare

Price

MBIO against its 20, 50 and 200-day averages
2050200
0.400.600.801.001.202.5M5.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MBIOclose 0.4320-day 0.3950-day 0.45200-day 0.660.4352w low

70.1% under the 52-week high of 1.43 on 28 Nov 2025. 52-week low 0.35 on 27 Oct 2026. Last 15 sessions, 39.7% high to low

Volume 0.90× normal · the line is the 50-bar volume average

Profile

MBIO
52-week range, 7% of the way up
0.351.43

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.

Employees4
IPOAug 22, 2017
Beta2.17
ATR, 14d0.03
Rel volume0.90
Short float1.09%
Insider own14.97%
Inst own6.73%

Snapshot

6 groups

Valuation

Index-
Market Cap3.25M
Enterprise Value-11.03M
Income-3.53M
Sales0.00M
Book/sh0.87
Cash/sh1.88
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees4
IPOAug 22, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.49
P/C0.23
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio1.85
Current Ratio1.85
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.52
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y91.14% 78.52%
Sales past 3/5Y- -
EPS Y/Y TTM59.14%
Sales Y/Y TTM-
EPS Q/Q-90.80%
Sales Q/Q-
Earnings-
EPS/Sales Surpr.-150.00% -

Ownership

Insider Own14.97%
Insider Trans0.00%
Inst Own6.73%
Inst Trans-0.17%
ROA-20.73%
ROE-43.15%
ROIC-53.58%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA209.58%
SMA50-4.81%
SMA200-35.39%
Trades-

Technical

Shs Outstand6.74M
Shs Float6.45M
Short Float1.09%
Short Ratio2.15
Short Interest0.07M
52W High1.43 -70.09%
52W Low0.35 22.10%
Volatility10.93% 8.50%
ATR (14)0.03
RSI (14)53.57
Beta2.17
Rel Volume0.90
Avg Volume32.72K
Volume29,316

Performance

Perf Week3.36%
Perf Month13.51%
Perf Quarter-28.00%
Perf Half Y-34.21%
Perf YTD-56.40%
Perf Year-65.51%
Perf 3Y-99.46%
Perf 5Y-99.98%
Perf 10Y-
Recom1.00
Target Price500.00
Prev Close0.45
Price0.43
Change %-5.08%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
May 18, 2021InitiatedBBTIG ResearchBuy$11+2,471.9%
Oct 02, 2020InitiatedBB. Riley FBRBuy$9+2,004.3%
Nov 20, 2019InitiatedCCantor FitzgeraldOverweight$7+1,536.7%
Aug 13, 2019InitiatedHH.C. WainwrightBuy$7+1,536.7%
Jun 21, 2019InitiatedCCantor FitzgeraldOverweight$7+1,536.7%
Dec 21, 2017InitiatedOOppenheimerOutperform$18+4,108.6%

Peers

Mkt cap
TickerCompanyMkt cap
TCRTAlaunos Therapeutics Inc6.65M
ESLAEstrella Immunopharma Inc34.53M
ATRAAtara Biotherapeutics Inc82.61M
CRBUCaribou Biosciences Inc42.21M
ACETAdicet Bio Inc27.99M
CLLSCellectis ADR99.82M
SNTISenti Biosciences Holdings Inc4.90M
GTBPGT Biopharma Inc8.14M
IPSCCentury Therapeutics Inc315.07M
NKTXNkarta Inc106.12M

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Herskowitz NeilDirectorDec 30 '25Sale0.96247238145Dec 30 04:17 PM
Chill Adam J.DirectorDec 30 '25Sale0.9544375Dec 30 04:16 PM
Jin DavidDirectorDec 30 '25Buy0.96247238286Dec 30 04:15 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2024Q32024-11-12-6.500-6.500-1.9140.000.001
2024Q22024-08-12-17.500-7.000-17.7290.000.001
2024Q12024-05-10-23.000-43.500-23.0640.00-1
2023Q42024-03-11-35.500-77.835-46.7230.000.003
2023Q32023-11-14-61.500-63.750-61.5430.000.002
2023Q22023-08-14-100-90.375-99.8780.000.004
2023Q12023-05-12-103-150.5-103.130.000.002
2022Q42023-03-29-135-142.5-137.180.000.005
2022Q32022-11-14-135-148.13-134.520.000.004
2022Q22022-08-11-142.5-156-139.140.000.005
2022Q12022-05-12-150-138-151.630.000.005
2021Q42022-03-23-165-144-159.240.000.005
2021Q32021-11-12-142.5-135.2-139.940.000.005
2021Q22021-08-16-120-145.5-122.990.000.005
2021Q12021-05-14-142.5-140-139.410.000.002
2020Q42021-03-24-240-155.63-241.670.000.003

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-930-611.25-9300.000.00
2018FY-855-735-853.320.000.05
2019FY-967.5-852.5-964.780.000.00
2020FY-855-759.38-855.910.000.00
2021FY-570-547.5-566.390.000.00
2022FY-562.5--562.140.00-
2023FY-300-365.83-3000.000.00
2024FY--40.500-25.836-0.00
2025FY--17.500-0.391-0.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2024Q4S2024-11-121000.000.000.00
2024Q4S2024-08-121000.000.000.00
2024Q4S2024-05-101000.000.000.00
2024Q4R2024-03-12100-0.92-0.92-0.92
2024Q4E2024-11-30100-0.11-0.11-0.11
2024Q4E2024-11-12110-0.11-0.11-0.11
2024Q4E2024-09-16110-0.11-0.11-0.11
2024Q4E2024-08-12100-0.16-0.16-0.16
2024Q4E2024-07-29100-0.16-0.16-0.16
2024Q4E2024-05-15101-0.16-0.16-0.16
2024Q4E2024-05-10100-0.15-0.15-0.15
2024Q4E2024-03-12100-0.92-0.92-0.92
2024Q3S2024-11-111000.000.000.00
2024Q3S2024-11-101000.000.000.00

Estimate history

EPS, annual-930-853.32-964.778-855.908-566.393-562.14-299.869-25.836-0.391-0.5179
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.914-0.95-0.054-0.19-0.075-0.074-0.142-0.159-0.143
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0000000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.0350.0370.0540.0960.1260.1430.1841.0037.2997.584
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.7531.0033.3734.3787.2997.2997.5777.5787.584
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.040.822.233.032.311.781.370.63
Gross Profit0.00-0.04-0.82-2.23-3.03-2.31-1.78-1.37-0.63
Selling, General and Administrative Excl. Other3.962.3911.7348.5073.1364.4255.0244.5230.59
Research and Development0.29-1.527.7539.1861.2353.5445.6235.0623.83
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-3.96-2.43-12.55-50.73-76.16-66.72-56.81-45.88-31.22
Interest Expense0.000.000.011.313.360.013.921.770.01
Unusual Expense0.000.003.692.790.000.000.00--
Net Income Before Taxes-3.53-1.92-15.75-51.60-77.53-66.37-60.02-46.39-30.66
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-3.53-1.92-15.75-51.60-77.53-66.37-60.02-46.39-30.66
Net Income From Continuing Operations-3.53-1.92-15.75-51.60-77.53-66.37-60.02-46.39-30.66
Net Income-3.53-1.92-15.75-51.60-77.53-66.37-60.02-46.39-30.66
EPS (Recurring)-0.52-0.39-21.60-288.50-562.14-566.39-855.91-964.78-853.32
EPS (Basic, Before Extraordinaries)-0.52-0.39-25.84-299.87-562.14-566.39-855.91-964.78-853.32
EPS (Diluted)-0.52-0.39-25.84-299.87-562.14-566.39-855.91-964.78-853.32
EBITDA-3.96-2.39-11.73-48.50-73.13-64.42-55.02-44.52-30.59
Non-Operating Income (Expense)0.430.510.503.231.990.370.711.260.57
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.070.13-0.450.572.283.312.992.664.96
Shares Outstanding7.587.301.000.180.140.130.100.050.04
Market Capitalization3.243.248.8811.2042.36156.75271.63164.2281.17

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.040.07
Gross Profit0.000.000.000.000.000.00-0.04-0.07
Selling, General and Administrative Excl. Other1.061.171.060.670.620.890.210.12
Research and Development0.210.220.18-0.32-0.330.10-0.960.12
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.06-1.17-1.06-0.67-0.62-0.89-0.25-0.20
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.001.04
Net Income Before Taxes-0.96-1.07-0.95-0.54-0.47-0.76-0.15-0.95
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-0.96-1.07-0.95-0.54-0.47-0.76-0.15-0.95
Net Income From Continuing Operations-0.96-1.07-0.95-0.54-0.47-0.76-0.15-0.95
Net Income-0.96-1.07-0.95-0.54-0.47-0.76-0.15-0.95
EPS (Recurring)-0.14-0.16-0.14-0.07-0.07-0.19-0.05-0.22
EPS (Basic, Before Extraordinaries)-0.14-0.16-0.14-0.07-0.07-0.19-0.05-0.95
EPS (Diluted)-0.14-0.16-0.14-0.07-0.07-0.19-0.05-0.95
EBITDA-1.06-1.17-1.06-0.67-0.62-0.89-0.21-0.12
Non-Operating Income (Expense)0.090.100.100.130.160.120.100.07
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.000.020.020.020.020.040.040.05
Shares Outstanding7.587.587.587.307.304.383.371.00
Market Capitalization3.245.325.527.1611.004.183.448.88

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments17.276.846.2375.66109.6297.8061.4134.0760.98
Short Term Receivables0.220.403.880.040.050.010.020.040.11
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets0.111.361.233.162.041.721.631.010.28
Total Current Assets17.598.6111.3578.85111.7199.5363.0635.1261.36
Net Property, Plant & Equipment0.000.454.8112.3112.109.129.136.861.38
Total Investments and Advances0.000.000.751.001.001.001.000.500.50
Intangible Assets0.00-------0.00
Other Assets0.000.250.830.260.360.250.250.270.25
Total Assets17.599.3117.7492.42125.17109.9073.4442.7563.49
Short Term Debt Incl. Current Port. of LT Debt0.000.460.520.610.350.281.510.000.00
Accounts Payable3.517.466.329.626.596.383.375.383.47
Other Current Liabilities4.404.698.534.883.872.862.890.240.14
Total Current Liabilities7.9112.6115.3715.1110.819.527.775.623.61
Long Term Debt0.000.421.9830.771.691.9514.020.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.150.150.270.270.270.000.000.740.05
Total Liabilities8.0613.1817.6246.1512.7711.4621.796.363.66
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity9.53-3.870.1246.27112.4098.4451.6536.4059.83
Total Shareholders Equity9.53-3.870.1246.27112.4098.4451.6536.4059.83
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity9.53-3.870.1246.27112.4098.4451.6536.4059.83
Total Liabilities & Stockholders Equity17.599.3117.7492.42125.17109.9073.4442.7563.49
Book Value Per Share1.31-3.860.67323.29892.741,028.71962.49988.661,710.38
Tangible Book Value Per Share1.31-3.860.67323.29892.741,028.71962.49988.661,710.38
Full-Time Employees46801131026251386
Price to Book Ratio0.49-2.292.790.661.392.763.182.234.83
Return on Assets-14.28-116.47-93.68-71.26-56.47-65.47-79.84-57.72-68.77
Return on Equity-67.93--222.44-97.72-62.96-79.97-105.37-63.73-74.40
Return on Invested Capital-20.16--2,456.07-100.63-58.18-59.78-70.64-84.25-52.29
Quick Ratio2.220.680.745.2210.3310.468.126.2516.99
Current Ratio2.220.680.745.2210.3310.468.126.2516.99

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-3.53-1.92-15.75-51.60-77.53-66.37-60.02-46.39-30.66
Depreciation0.000.040.822.233.032.311.781.370.63
Other Funds (Non Cash)-0.50-1.704.152.885.4011.0317.8211.318.32
Funds from Operations-4.03-3.58-10.78-46.50-69.10-53.03-40.41-33.71-21.71
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.54-1.68-0.63-2.984.03-0.643.090.132.47
Cash from Operating Activities-4.57-5.26-11.41-49.48-65.07-53.67-37.32-33.58-19.24
Capital Expenditures0.000.000.00-0.11-3.08-5.37-4.41-3.69-7.95
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.001.170.006.000.130.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.0017.608.50
Purchase of Investments0.000.000.000.000.000.000.000.00-52.50
Sale Or Maturity of Investments0.000.000.000.000.000.000.0017.6061.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.001.170.005.89-2.95-5.37-4.4113.910.56
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.0014.5311.274.296.7170.8593.8751.510.18
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.0014.5311.274.296.7170.8593.8751.510.18
Proceedsfrom Stock Options0.007.387.694.126.5070.5493.5251.510.00
Issuance or Reduction of Debt, Net0.000.000.00-30.3827.350.00-15.7513.610.00
Change in Long Term Debt0.000.000.00-30.3827.350.00-15.7513.610.00
Issuance of Long Term Debt0.000.000.000.0027.350.000.0013.610.00
Reduction of Long Term Debt0.000.000.00-30.380.000.00-15.750.000.00
Net Financing Active Other Cash Flow-0.140.000.000.000.000.000.000.000.00
Other Financing Activities Uses-0.140.000.000.000.000.000.000.000.00
Cash from Financing Activities-0.1414.5311.27-26.0834.0670.8578.1265.120.18
Net Change in Cash-4.7110.43-0.14-69.67-33.9611.8136.3945.44-18.51
Free Cash Flow-4.57-5.26-11.41-49.54-67.78-57.65-39.24-35.93-26.11
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments14.2815.1516.2617.2718.9812.66
Short Term Receivables0.220.220.220.220.220.22
Inventories0.000.000.000.000.000.00
Other Current Assets0.190.250.110.110.160.17
Total Current Assets14.6815.6116.5817.5919.3613.05
Net Property, Plant & Equipment0.000.000.000.000.000.00
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.00
Total Assets14.6815.6116.5817.5919.3613.05
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable3.123.213.343.514.995.65
Other Current Liabilities4.834.704.504.404.454.35
Total Current Liabilities7.957.927.847.919.4410.00
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.150.150.150.150.150.15
Total Liabilities8.108.077.998.069.5910.15
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity6.597.548.609.539.772.89
Total Shareholders Equity6.597.548.609.539.772.89
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity6.597.548.609.539.772.89
Total Liabilities & Stockholders Equity14.6815.6116.5817.5919.3613.05
Book Value Per Share0.871.001.131.311.340.66
Tangible Book Value Per Share0.871.001.131.311.340.66
Full-Time Employees---4--
Price to Book Ratio0.490.620.560.732.300.89
Return on Assets-20.73-21.17-17.29-14.28-17.59-30.39
Return on Equity-43.15-58.12-44.62-67.93-418.83-
Return on Invested Capital-14.64-14.21-11.11-5.65-4.79-26.35
Quick Ratio1.851.972.122.222.051.30
Current Ratio1.851.972.122.222.051.30

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.96-1.07-0.95-0.54-0.47-0.76
Depreciation0.000.000.000.000.000.00
Other Funds (Non Cash)0.00-0.01-0.05-0.43-0.38-0.75
Funds from Operations-0.96-1.08-1.01-0.97-0.84-1.51
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.090.120.00-0.740.030.17
Cash from Operating Activities-0.88-0.97-1.01-1.72-0.82-1.34
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.000.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.007.14-0.23
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.007.14-0.23
Proceedsfrom Stock Options0.000.000.000.000.00-0.23
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.00-0.140.000.000.000.00
Other Financing Activities Uses-0.00-0.140.000.000.000.00
Cash from Financing Activities0.00-0.140.000.007.14-0.23
Net Change in Cash-0.87-1.11-1.01-1.726.33-1.57
Free Cash Flow-0.88-0.97-1.01-1.72-0.82-1.34

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.09%0.1M6.4M31.15K
2026-10-150.91%0.1M6.4M31.96K
2026-09-300.82%0.1M6.4M29.61K
2026-09-150.91%0.1M6.4M32.55K
2026-08-310.85%0.1M6.4M123.98K
2026-08-140.82%0.1M6.4M130.60K
2026-07-310.86%0.1M6.4M131.25K
2026-07-150.95%0.1M6.4M135.23K
2026-06-301.59%0.1M6.4M132.19K
2026-06-152.34%0.2M6.4M129.13K
2026-05-290.85%0.1M6.4M39.79K
2026-05-150.83%0.1M6.4M39.23K
2026-04-301.12%0.1M6.4M164.99K
2026-04-151.57%0.1M6.4M167.95K
2026-03-311.95%0.1M6.4M172.54K
2026-03-131.38%0.1M6.2M184.73K
2026-02-272.18%0.1M6.2M193.81K
2026-02-133.57%0.2M6.2M201.70K
2026-01-300.71%0.0M6.2M83.39K
2026-01-150.65%0.0M6.2M92.02K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-05S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-158-KCurrent report2026-10-13SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-274Statement of changes in beneficial ownership of securities2026-04-24SEC
2026-04-178-KCurrent report2026-04-15SEC
2026-03-1910-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-01-054Statement of changes in beneficial ownership of securities2026-01-02SEC
2026-01-05SCHEDULE 13D/ASEC
2025-12-304Statement of changes in beneficial ownership of securities2025-12-30SEC
2025-12-304Statement of changes in beneficial ownership of securities2025-12-30SEC
2025-12-304Statement of changes in beneficial ownership of securities2025-12-30SEC
2025-12-238-KCurrent report2025-12-17SEC
2025-12-03DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-22SEC
2025-11-0710-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-10-014Statement of changes in beneficial ownership of securities2025-09-29SEC
2025-10-01SCHEDULE 13D/ASEC
2025-09-05424B5SEC
2025-08-12SCHEDULE 13G/ASEC
2025-08-0810-QQuarterly report pursuant to Section 13 or 15(d)2025-06-30SEC
2025-07-098-KCurrent report2025-07-07SEC
2025-05-15SCHEDULE 13G/ASEC
2025-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2025-03-31SEC
2025-05-09SCHEDULE 13G/ASEC
2025-04-284Statement of changes in beneficial ownership of securities2025-04-24SEC
2025-04-11EFFECTEffectiveness filing by commission orderSEC
2025-04-04POS AMPost-effective amendment to a registration statement that is not immediately effective upon filingSEC
2025-04-024Statement of changes in beneficial ownership of securities2025-03-31SEC
2025-04-02SCHEDULE 13D/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-1223812412
2025-110000

Institutional holders

Manager% owned
Kestra Advisory Services, LLC2.15%
BlackRock, Inc.1.12%
CITADEL ADVISORS LLC0.78%
GEODE CAPITAL MANAGEMENT, LLC0.54%
CFO4Life Group, LLC0.44%
VANGUARD FIDUCIARY TRUST CO0.42%
VANGUARD CAPITAL MANAGEMENT LLC0.34%
XTX Topco Ltd0.19%
Virtu Financial LLC0.19%
TWO SIGMA SECURITIES, LLC0.18%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.45%
VANGUARD EXTENDED MARKET INDEX FUND0.34%
Fidelity Series Total Market Index Fund0.06%
Fidelity Total Market Index Fund0.01%
Nomura Healthcare Fund0.00%

OakChart. MBIO. Cached 15 minutes.